Lu Y - Search Results

1

Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice.

Lu Y, Xu LC, Parker N, Westrick E, Reddy JA, Vetzel M, Low PS, Leamon CP. Lu Y, et al. Mol Cancer Ther. 2006 Dec;5(12):3258-67. doi: 10.1158/1535-7163.MCT-06-0439. Mol Cancer Ther. 2006. PMID: 17172429

2

Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.

Chu H, Shillingford JM, Reddy JA, Westrick E, Nelson M, Wang EZ, Parker N, Felten AE, Vaughn JF, Xu LC, Lu YJ, Vlahov IR, Leamon CP. Chu H, et al. Mol Pharm. 2019 Sep 3;16(9):3985-3995. doi: 10.1021/acs.molpharmaceut.9b00624. Epub 2019 Aug 13. Mol Pharm. 2019. PMID: 31356752

3

Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.

Lu Y, Low PS. Lu Y, et al. Cancer Immunol Immunother. 2002 May;51(3):153-62. doi: 10.1007/s00262-002-0266-6. Epub 2002 Mar 19. Cancer Immunol Immunother. 2002. PMID: 11941454 Free PMC article.

4

Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.

Lu Y, Sega E, Leamon CP, Low PS. Lu Y, et al. Adv Drug Deliv Rev. 2004 Apr 29;56(8):1161-76. doi: 10.1016/j.addr.2004.01.009. Adv Drug Deliv Rev. 2004. PMID: 15094213 Review.

5

Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells.

Lu Y, Sega E, Low PS. Lu Y, et al. Int J Cancer. 2005 Sep 20;116(5):710-9. doi: 10.1002/ijc.21126. Int J Cancer. 2005. PMID: 15828051

6

Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential.

Lu Y, You F, Vlahov I, Westrick E, Fan M, Low PS, Leamon CP. Lu Y, et al. Mol Pharm. 2007 Sep-Oct;4(5):695-706. doi: 10.1021/mp070050b. Epub 2007 Sep 5. Mol Pharm. 2007. PMID: 17784727

7

Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.

Sega EI, Lu Y, Ringor M, Leamon CP, Low PS. Sega EI, et al. Among authors: lu y. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):559-66. doi: 10.1016/j.ijrobp.2008.02.010. Epub 2008 Apr 12. Int J Radiat Oncol Biol Phys. 2008. PMID: 18411004

8

Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer.

Lu Y, Klein PJ, Westrick E, Xu LC, Santhapuram HK, Bloomfield A, Howard SJ, Vlahov IR, Ellis PR, Low PS, Leamon CP. Lu Y, et al. AAPS J. 2009 Sep;11(3):628-38. doi: 10.1208/s12248-009-9139-7. AAPS J. 2009. PMID: 19728104 Free PMC article.

9

Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.

Lu Y, Stinnette TW, Westrick E, Klein PJ, Gehrke MA, Cross VA, Vlahov IR, Low PS, Leamon CP. Lu Y, et al. Arthritis Res Ther. 2011 Apr 4;13(2):R56. doi: 10.1186/ar3304. Arthritis Res Ther. 2011. PMID: 21463515 Free PMC article.

10

Folate-Hapten-Mediated Immunotherapy Synergizes with Vascular Endothelial Growth Factor Receptor Inhibitors in Treating Murine Models of Cancer.

Bandara NA, Bates CD, Lu Y, Hoylman EK, Low PS. Bandara NA, et al. Among authors: lu y. Mol Cancer Ther. 2017 Mar;16(3):461-468. doi: 10.1158/1535-7163.MCT-16-0569. Epub 2016 Dec 15. Mol Cancer Ther. 2017. PMID: 27980109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,763 results

Search Page

Filters